Acetazolamide for the Treatment of Chronic Paroxysmal Hemicrania

Authors

  • John S. Warner M.D.,

    Professor, Corresponding author
    1. Department of Neurology and Director, The Vanderbilt Headache Clinic, Vanderbilt University, Nashville, TN
      John S, Warner, M.D., The Vanderbilt Headache Clinic, 362A Medical Center South, 2100 Pierce Avenue, Nashville, TN 37212.
    Search for more papers by this author
  • Artur W. Wamil M.D., Ph.D.,

    Search for more papers by this author
    • 2Research Assistant Professor of Neurology, Vanderbilt University, Nashville, Tennessee, and Instructor in Pharmacology and Clinical Pharmacology, Lublin Medical University, Lublin, Poland

  • Michael J McLean M.D., Ph.D.

    Associate Professor
    1. Department of Neurology and Consulting Neuropharmacologist to The Vanderbilt Headache Clinic, Nashville, TN
    Search for more papers by this author

John S, Warner, M.D., The Vanderbilt Headache Clinic, 362A Medical Center South, 2100 Pierce Avenue, Nashville, TN 37212.

Abstract

SYNOPSIS

A 25-year-old patient presented with clinical characteristics of chronic paroxysmal hemicrania which failed to respond to indomethacin 300 mg daily. Total relief of headaches was obtained with acetazolamide 250 mg t.i.d.

Ancillary